Tarah Ballinger: Excited to present results of this trial focused solely on Black people with breast cancer at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a post by ECOG-ACRIN Cancer Research Group, on X/Twitter, adding:
”Excited to present results of this trial focused solely on Black people with breast cancer at ASCO24 adjuvant breast session.
Picture below highlights patient recruitment efforts developed with advocate extraordinaire Lisa Hayes.”
Quoting ECOG-ACRIN Cancer Research Group’s post:
”Results of ECOG-ACRIN Cancer Research Group EAZ171 prospective validation of germline variants and taxane type in associated with taxane-induced peripheral neuropathy in Black women with early breast cancer at ASCO24 by Tarah Ballinger, IU Simon Comprehensive Cancer Center.
Monday 6/3, 3PM CT, Hall B1+livestream LBA503.”
Read further.
Source: Tarah Ballinger/X and ECOG-ACRIN Cancer Research Group/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023